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Old bugs for new tasks; the microbial offer in the proteomics era
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Microbial transformations have been unnoticeably ex-
ploited by mankind for centuries especially in the context
of early food industries. The modern biotechnology uses
microbial cells in a more directed approach to produce
enzymes, antibiotics, amino acids and other metabolites
of economical interest. Food and mining industries are
also sustained by natural microbial activities tailored in a
way that favours the desired transformations. The birth of
genetic engineering in the late 70's and its further techni-
cal expansion have provided molecular tools to engineer
and produce hetereologous proteins in a diversity of mi-
croorganisms including bacteria, yeast and filamentous
fungi, thus largely extending their manufacturing capabil-
ities.
Nowadays, the main sources of proteins for research are
genetically modified microorganisms. However, industri-
al production of such proteins has not been as successful
as initially expected and in many cases, the yield of the
processes is low and hard to justify, from an economical
point of view, a large-scale recombinant production. Pro-
ducer cells commonly suffer from protein-promoted tox-
icity, often resulting in slow growth, cell death and
plasmid instability. On the other side, recombinant pro-
teins, apart from overloading the cells with extra metabol-
ic demands, often undergo proteolysis and/or aggregate as
inactive polypeptides into inclusion bodies. These events
derive from the incapability of foreign proteins, as pro-
duced at high non-physiological rates, to fold into their
native conformation. Although the exploration of differ-
ent cell systems can permit to escape from the above listed
obstacles (that on the other hand, are rather unpredictable
for a given protein), some of them can be surmounted by
genetic, protein and metabolic engineering approaches
and/or by process and downstream optimisation. Intrigu-
ingly, the emerging need for a wide-spectrum, efficient
protein production in the proteomics era has favoured a
deeper analysis of the recombinant cell physiology. In this
regard, scientists have turned their attention to the cells
rather than merely observing the products. The Cell Facto-
ry concept is then completely structured through the ex-
amination of the metabolic capabilities of the producer
cells in close relationship with the nature and features of
the product (recombinant or not) and the production
process itself. The consequent identification of main bot-
tlenecks encountered during production, as well as the
cell responses triggered under this situation reveals the in-
tegrated nature and complexity of the machinery involved
in biosynthesis and quality control and also its connex-
ions with the mechanisms coping with stress at both cel-
lular and populational levels. Based on these findings, we
can now better approach improved strategies to adapt old
microbes to new production requirements for both natu-
ral and engineered products.
Experimental results relevant to both natural and recom-
binant microbial factories are dropping in microbiology,
genetics, biotechnology, biochemistry, chemical engi-
neering and environmental journals. Microbial Cell Fac-
tories [http://www.microbialcellfactories.com/start.asp],
published online by BioMed Central [http://www.bi-
Published: 25 October 2002
Microbial Cell Factories 2002, 1:4
Received: 23 October 2002
Accepted: 25 October 2002
This article is available from: http://www.microbialcellfactories.com/content/1/1/4
© 2002 Villaverde; licensee BioMed Central Ltd. This article is published in Open Access: verbatim copying and redistribution of this article are permitted 
in all media for any purpose, provided this notice is preserved along with the article's original URL.Page 1 of 2
(page number not for citation purposes)
Microbial Cell Factories 2002, 1 http://www.microbialcellfactories.com/content/1/1/4omedcentral.com/] since February 2002, offers a new fo-
rum for the fast publication of research in this field,
addressing both product-focused and cell-focused aspects
of the microbial production and transformations. The
topics covered by the journal include recombinant DNA
technologies, genetic engineering, plasmid construction
and maintenance, gene cloning and expression, develop-
ment of new expression systems, protein engineering,
protein production, proteolysis and aggregation of recom-
binant proteins, cell stress responses, bioreactor design
and operation, process control and monitoring, scale-up,
downstream procedures, protein folding and refolding,
production of natural substances, mutagenesis, strain im-
provement and screening, metabolic engineering, micro-
bial transformations, food microbiology, extremophile
biology and biosensors. Manuscripts submitted to Micro-
bial Cell Factories through our online submission system
[http://www.microbialcellfactories.com/manuscript/] are
immediately sent to two external referees plus one mem-
ber of the international editorial board [http://www.mi-
crobialcellfactories.com/edboard/], who are requested to
respond within 15 days. Therefore, manuscripts showing
sufficient merits for publication can be accepted only a
few weeks after submission, depending on the speed of
the authors to address eventual referees' concerns. After
acceptance, the publication online is immediate and the
manuscript is finally replaced by the definitive pdf form
once the proofs have been approved by the authors. The
inclusion in PubMed [http://www.ncbi.nlm.nih.gov/ent-
rez/query.fcgi?db=PubMed&cmd=Search&term=1475-
2859] databases (with the journal abbreviation Microb
Cell Fact) usually takes a few days. Costs of publication
and maintenance of papers in databases are defrayed by
the authors through reasonable processing charges. Waiv-
ers are considered upon request and authors who are
members of institutions joining the BioMed Central
membership programme [http://www.biomedcen-
tral.com/info/instmembership.asp] are not charged. The
publication of a manuscript in Microbial Cell Factories
implies that it is immediately and freely available to all of
the scientific community through the journal home site,
the BioMed Central web site and PubMed databases. The
authors retain the copyright of their research and manu-
scripts are permanently stored electronically by the re-
search depository PubMed Central, which is run by the US
National Institutes of Health (NIH). The publication pol-
icy [http://www.microbialcellfactories.com/info/faq/de-
fault.asp?txt_faq_no=1] supported by Microbial Cell
Factories and its publisher BioMed Central represents a
new and revolutionary approach on the road to the fric-
tionless and worldwide spread of science. Microbial Cell
Factories is now the fastest way for the broad communica-
tion of your experimental research, improved protocols or
literature review in any facet of microbial production.Page 2 of 2
(page number not for citation purposes)
